D
David Navarro
Researcher at University of Valencia
Publications - 309
Citations - 4969
David Navarro is an academic researcher from University of Valencia. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 31, co-authored 252 publications receiving 3549 citations.
Papers
More filters
Journal ArticleDOI
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
Eliseo Albert,Ignacio Torres,Felipe Bueno,Dixie Huntley,Estefanía Molla,Miguel Ángel Fernández-Fuentes,Mireia Martínez,Sandrine Poujois,Lorena Forqué,Arantxa Valdivia,Carlos Solano de la Asunción,Josep Ferrer,Javier Colomina,David Navarro +13 more
TL;DR: The data suggested that patients with RT-PCR-proven COVID-19 testing negative by RAD are unlikely to be infectious, and the Panbio™ CO VID-19 Ag Rapid Test Device performed well as a POCT for early diagnosis in primary healthcare centers.
Journal ArticleDOI
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman,Rafael de la Cámara,Christine Robin,Roberto Crocchiolo,Hermann Einsele,Joshua A. Hill,Petr Hubacek,David Navarro,Catherine Cordonnier,Katherine N. Ward +9 more
TL;DR: This Review summarises the reviewed literature and the recommendations of the ECIL 7 for management of cytomegalovirus in patients with haematological malignancies and covers diagnosis, preventive strategies such as prophylaxis and pre-emptive therapy, and management.
Journal ArticleDOI
Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction–Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial
José María Aguado,Lourdes Vázquez,Mario Fernández-Ruiz,Teresa Villaescusa,Isabel Ruiz-Camps,Pere Barba,Jose T. Silva,Montserrat Batlle,Carlos Solano,David Gallardo,Inmaculada Heras,Marta Polo,Rosario Varela,Carlos Vallejo,Teresa Olave,Javier López-Jiménez,Montserrat Rovira,Rocío Parody,Manuel Cuenca-Estrella,Marta Polo Zarzuela,Francisco J. Candel González,Paloma Merino Amador,Joaquín Díaz Mediavilla,Isabel Ruiz Camps,Nerea Castillo,María Teresa Martín,Jordi Andreu Soriano,Inmaculada Heras Fernando,Cristina Castilla-Llorente,Rosa Cesteros,María Remedios Rodríguez Mondéjar,Dolores Caballero,José Elías García,Inmaculada García García,Sara de la Mano González,Jose María Fernandez García-Hierro,Mar Tormo,David Navarro,Miguel Angel Molla,Ana J. González,Soledad González,Ana Pilar González,Pilar Palomo,Rocío Parody Porras,Ramón Guardia Sánchez,María Rosario Varela,María Teresa Olave Rubio,Javier López Jiménez,Montserrat Rovira Tarrats,María Suárez-Lledó Grande,Francesc Fernández-Avilés,José Tiago Silva,María José Buitrago,Teresa Merino Amador,Leticia Bernal-Martínez +54 more
TL;DR: A combined monitoring strategy based on serum GM and Aspergillus DNA was associated with an earlier diagnosis and a lower incidence of IA in high-risk hematological patients.
Journal ArticleDOI
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
TL;DR: In this article, the Panbio™ COVID-19 Ag Rapid Test Device (Abbott Diagnostics, Jena, Germany) was evaluated for detecting SARS-CoV-2-infected asymptomatic individuals.
Journal ArticleDOI
Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.
Concepción Gimeno,Carlos Solano,José C. Latorre,Juan C. Hernández-Boluda,María Ángeles Clari,María José Remigia,Santiago Furió,Marisa Calabuig,Nuria Tormo,David Navarro +9 more
TL;DR: The plasma real-time PCR from Abbott is more suitable than the antigenemia assay for monitoring active CMV infection in Allo-SCT recipients and may be used for guiding preemptive therapy in this clinical setting.